EBS

Emergent Biosolutions Inc

6.23

Oct 22 • 3:59 PM ET +0.03 (0.48%)

6.23

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - Specialty & Generic USA Small NYSE

Peers: SIGA KMDA INDV TEVA ADMA NVAX TNXP GOVX VIR SNGX

| Held by: AVUV XBI VTI IWM DFSV VXF SMLF FESM DFAT IWN

Scroll to Statements

Index	RUT
Market Cap	319.43M
Enterprise Value	766.73M
Income	-176.80M
Sales	770.20M
Book/sh	6.65
Cash/sh	2.75
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	900
IPO	Nov 15, 2006

P/E	-
Forward P/E	5.95
PEG	7.17
P/S	0.41
P/B	0.94
P/C	2.27
P/FCF	3.72
EV/EBITDA	3.29
EV/Sales	1.00
Quick Ratio	2.95
Current Ratio	5.42
Debt/Eq	1.72
LT Debt/Eq	1.72
Option/Short	Yes / Yes

EPS (ttm)	-3.55
EPS next Y	1.05
EPS next Q	-0.39
EPS this Y	-76.50%
EPS next Y	190.99%
EPS next 5Y	0.83%
EPS past 3/5Y	- -30.38%
Sales past 3/5Y	-12.72% -13.74%
EPS Y/Y TTM	-231.68%
Sales Y/Y TTM	-9.56%
EPS Q/Q	-1477.33%
Sales Q/Q	66.29%
Earnings	Nov 02 AMC
EPS/Sales Surpr.	805.88% 32.00%

Insider Own	5.96%
Insider Trans	-2.73%
Inst Own	88.10%
Inst Trans	2.97%
ROA	-13.95%
ROE	-40.29%
ROIC	-19.05%
Gross Margin	47.17%
Oper. Margin	17.77%
Profit Margin	-22.96%
SMA20	-7.32%
SMA50	0.11%
SMA200	-24.01%
Trades

Shs Outstand	51.30M
Shs Float	48.21M
Short Float	19.28%
Short Ratio	7.79
Short Interest	9.29M
52W High	14.06 -55.69%
52W Low	4.36 42.89%
Volatility	5.25% 5.56%
ATR (14)	0.38
RSI (14)	42.98
Beta	2.38
Rel Volume	0.70
Avg Volume	1.19M
Volume	838,570

Perf Week	-13.23%
Perf Month	-6.60%
Perf Quarter	-14.19%
Perf Half Y	-22.99%
Perf YTD	-49.60%
Perf Year	-33.93%
Perf 3Y	181.90%
Perf 5Y	-87.50%
Perf 10Y	-77.86%
Recom	2.33
Target Price	11.00
Prev Close	6.20
Price	6.23
Change %	0.48%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-21-26	Resumed	JP Morgan	Underweight
Dec-30-24	Initiated	H.C. Wainwright	Buy	$15
Aug-22-24	Initiated	Rodman & Renshaw	Buy	$16
Mar-07-24	Upgrade	The Benchmark Company	Hold → Buy	$5
Nov-20-23	Resumed	JP Morgan	Underweight
Aug-29-23	Downgrade	The Benchmark Company	Buy → Hold
Apr-10-23	Upgrade	The Benchmark Company	Hold → Buy	$22
Mar-17-23	Downgrade	JP Morgan	Neutral → Underweight	$23 → $9
Nov-10-22	Downgrade	The Benchmark Company	Buy → Hold
Apr-29-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-20-22	Upgrade	The Benchmark Company	Hold → Buy	$77
Nov-08-21	Downgrade	The Benchmark Company	Buy → Hold
May-05-21	Downgrade	Argus	Buy → Hold
Apr-07-21	Initiated	The Benchmark Company	Buy	$150
Feb-24-21	Upgrade	Chardan Capital Markets	Neutral → Buy	$112
Feb-19-21	Downgrade	Chardan Capital Markets	Buy → Neutral	$112
Jan-08-21	Downgrade	Wells Fargo	Overweight → Equal Weight	$110
Sep-14-20	Resumed	JP Morgan	Neutral	$103
Jul-31-20	Reiterated	Chardan Capital Markets	Buy	$86 → $112
Sep-12-19	Initiated	Guggenheim	Buy

Show Previous Ratings

Oct-16-26 11:41AM	Emergent BioSolutions stock falls as CFO plans retirement (Investing.com) -11.14%
07:50AM	Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl (Business Wire)
Oct-15-26 08:00AM	Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026 (Business Wire)
Oct-06-26 06:47AM	Healthcare-linked stocks extend gains following possible plague death (MarketWatch)
Oct-05-26 11:34PM	NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards' (Stocktwits) +14.38%
07:45AM	Loading…
Sep-15-26 07:45AM	Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility (GlobeNewswire)
Sep-03-26 07:45AM	Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes (GlobeNewswire)
Sep-01-26 07:55AM	Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted) (GlobeNewswire)
Aug-31-26 07:55AM	Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN Nasal Spray (GlobeNewswire)
07:54AM	Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day (GlobeNewswire)
Aug-11-26 12:02AM	Why Did TTD, PZZA, EBS Stocks Plummet To 52 Week Lows? (Stocktwits)
Aug-06-26 08:30AM	Emergent BioSolutions Inc. Q2 2026 Earnings Call Summary (Moby) -29.58%
Aug-05-26 04:28PM	Emergent Biosolutions: Q2 Earnings Snapshot (Associated Press)
04:07PM	Emergent BioSolutions Reports Second Quarter 2026 Financial Results (GlobeNewswire)
04:07PM	Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment (GlobeNewswire)
04:01PM	Loading…
Jul-22-26 04:01PM	Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
Jun-29-26 09:13AM	Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government (GlobeNewswire)
Jun-04-26 08:02AM	Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day to Help Save Lives from Opioid Overdose (GlobeNewswire) +6.43%
May-28-26 04:01PM	Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] to Support U.S. Biodefense Strategy (GlobeNewswire)
May-20-26 07:30AM	Emergent BioSolutions to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-18-26 08:59AM	Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000 [Smallpox and Mpox (Vaccinia) Vaccine, Live] (GlobeNewswire)
May-01-26 08:30AM	Emergent BioSolutions Inc. Q1 2026 Earnings Call Summary (Moby)
03:19AM	Emergent BioSolutions Inc (EBS) Q1 2026 Earnings Call Highlights: Strong Revenue and Strategic ... (GuruFocus.com)
Apr-30-26 05:20PM	Emergent Biosolutions: Q1 Earnings Snapshot (Associated Press)
04:30PM	Emergent BioSolutions Reports First Quarter 2026 Financial Results (GlobeNewswire)
07:55AM	Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox (GlobeNewswire)
Apr-29-26 07:35AM	Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142 (GlobeNewswire)
06:53AM	Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN Nasal Spray Among Canadians and Help Save Lives (GlobeNewswire)
Apr-28-26 08:01AM	Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States (GlobeNewswire)
Apr-16-26 04:05PM	Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026 (GlobeNewswire)
04:05PM	Loading…
04:05PM	Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility (GlobeNewswire)
Apr-09-26 04:25PM	Emergent BioSolutions Partners with British Columbia to Supply NARCAN Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program (GlobeNewswire) -5.80%
02:34PM	McKinsey Will Add $125 Million to Purdue's $7 Billion Bankruptcy Settlement (Moby)
Apr-07-26 08:05AM	Emergent BioSolutions Launches New NARCAN Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness (GlobeNewswire)
Apr-02-26 08:00AM	Emergent BioSolutions Participates in Upcoming International Preparedness Conferences (GlobeNewswire)
Mar-25-26 04:15PM	Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures (GlobeNewswire)
Mar-17-26 12:49PM	Mpox Is on the Rise in the U.S. 3 Vaccine Stocks Worth a Second Look. (Barrons.com)
Mar-03-26 08:00AM	Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors (GlobeNewswire)
Feb-28-26 01:07AM	Emergent Biosolutions Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 02:43AM	Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today? (New feeds test provider finance) -26.58%
12:04AM	Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ... (GuruFocus.com)
Feb-26-26 04:58PM	Emergent Biosolutions: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
04:01PM	Emergent BioSolutions Announces New $50 Million Stock Repurchase Program (GlobeNewswire)
04:01PM	Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness (GlobeNewswire)
Feb-13-26 07:55AM	Emergent BioSolutions Wins FDA Approval For New Narcan Multipacks To Expand Overdose Access (Benzinga)
Feb-12-26 06:00PM	Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN Nasal Spray Multipacks (GlobeNewswire)
09:02AM	Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Jan-16-26 10:26AM	?Emergent BioSolutions (EBS) Receives a New Order from US Department of War (Insider Monkey)
07:46AM	Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading (Benzinga)
06:24AM	Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading (BioPharma Dive)
Jan-15-26 01:08PM	NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading (The Wall Street Journal) -12.68%
Jan-14-26 08:00AM	Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness (GlobeNewswire)
Jan-12-26 07:30AM	Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation (GlobeNewswire)
Jan-08-26 04:30PM	Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 (GlobeNewswire)
08:00AM	Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa (GlobeNewswire)
Jan-07-26 07:59AM	Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 (GlobeNewswire) +5.70%
Dec-12-25 08:30AM	Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site (GlobeNewswire)
Dec-04-25 11:30AM	Qiagen (QGEN) Up 6.3% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-18-25 08:00AM	Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access (GlobeNewswire)
Nov-12-25 04:01PM	Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors (GlobeNewswire)
09:15AM	Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run? (Zacks)
Nov-07-25 08:55AM	Looking for a Fast-paced Momentum Stock at a Bargain? Consider Emergent Biosolutions (EBS) (Zacks)
Oct-31-25 09:15AM	Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out? (Zacks)
Oct-30-25 04:08PM	Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ... (GuruFocus.com) +36.60%
Oct-29-25 06:05PM	Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates (Zacks)
05:01PM	Emergent Biosolutions: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Emergent BioSolutions Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-28-25 08:00AM	Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness (GlobeNewswire)
Oct-08-25 07:45AM	Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 (GlobeNewswire)
Sep-24-25 04:05PM	Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone (GlobeNewswire) +5.43%
02:05PM	3 Small-Cap Stocks to Watch After the Fed's Rate Cuts (MarketBeat)
Sep-19-25 08:34AM	Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner (GlobeNewswire)
Sep-15-25 08:35AM	Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain (GlobeNewswire)
Sep-09-25 12:10PM	US Government signs $56m smallpox/mpox vaccine order despite political disarray (Pharmaceutical Technology) +9.26%
07:30AM	Emergent BioSolutions Receives New Contract Modification for ACAM2000, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness (GlobeNewswire)
Sep-02-25 07:40AM	Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use (GlobeNewswire)
Aug-29-25 08:05AM	Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day (GlobeNewswire)
Aug-27-25 08:01AM	Emergent BioSolutions to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-21-25 08:45AM	Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day (GlobeNewswire)
Aug-18-25 09:45AM	Big Rallies Brewing? 3 Analyst Favorites to Watch Closely (MarketBeat)
Aug-07-25 10:16AM	Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma (GlobeNewswire) +36.65%
Aug-06-25 05:22PM	Emergent Biosolutions: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Emergent BioSolutions Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-28-25 08:50AM	New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox (GlobeNewswire) -5.44%
08:50AM	Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives (GlobeNewswire)
Jul-15-25 07:30AM	Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025 (GlobeNewswire) -5.07%
Jul-08-25 04:45PM	Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016 [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts (GlobeNewswire) +6.70%
Jul-02-25 04:05PM	Emergent BioSolutions Expands NARCANDirect to Offer KLOXXADO (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate (GlobeNewswire) +7.73%
Jun-23-25 08:05AM	Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] to Bolster U.S. Biodefense Supply (GlobeNewswire)
Jun-20-25 08:13AM	Emergent BioSolutions Announces Addition to Russell 3000 Index (GlobeNewswire)
Jun-05-25 07:00AM	Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies (GlobeNewswire)
May-29-25 09:55AM	5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost (Zacks)
May-19-25 09:43AM	Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions (Zacks)
May-16-25 10:52AM	5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes (Zacks) +20.95%
May-14-25 07:32AM	Emergent BioSolutions to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-08-25 09:53AM	Q1 2025 Emergent BioSolutions Inc Earnings Call (Thomson Reuters StreetEvents) +34.18%
03:33AM	Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... (GuruFocus.com)
May-07-25 10:03PM	Emergent biosolutions reaffirms 2025 revenue guidance of $750M-$850M amid turnaround progress (Seeking Alpha)
10:01PM	Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript (Seeking Alpha)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DONALD DEGOLYER	Director	Oct 07 '26	Proposed Sale	7.09	17,800	126,120		Oct 07 04:03 PM
DeGolyer Donald W	Director	Oct 07 '26	Sale	7.09	17,800	126,202	111,921	Oct 07 03:45 PM
Williams Paul Anthony	SVP, Products Business	Oct 01 '26	Sale	6.53	3,000	19,590	156,098	Oct 05 09:16 AM
PAUL WILLIAMS	Officer	Oct 01 '26	Proposed Sale	6.53	3,000	19,592		Oct 01 04:20 PM
Williams Paul Anthony	SVP, Products Business	Jul 01 '26	Sale	8.40	3,000	25,200	159,098	Jul 02 12:57 PM
PAUL WILLIAMS	Officer	Jul 01 '26	Proposed Sale	8.40	3,000	25,205		Jul 01 04:12 PM
Dayal Sujata Tyagi	Director	May 01 '26	Sale	8.40	13,761	115,610	100,563	May 04 05:30 PM
DeGolyer Donald W	Director	May 01 '26	Sale	8.40	15,481	129,994	129,721	May 04 05:30 PM
Katkin Keith	Director	Apr 30 '26	Sale	8.28	15,481	128,183	96,294	May 04 05:29 PM
Zoon Kathryn C	Director	May 01 '26	Sale	8.40	17,202	144,453	79,941	May 04 05:28 PM
SUJATA TYAGI DAYAL	Director	May 01 '26	Proposed Sale	8.40	13,761	115,612		May 01 04:20 PM
KATHRYN ZOON	Director	May 01 '26	Proposed Sale	8.40	17,202	144,492		May 01 04:03 PM
DONALD DEGOLYER	Director	May 01 '26	Proposed Sale	8.40	15,481	130,064		May 01 04:02 PM
KEITH KATKIN	Director	Apr 30 '26	Proposed Sale	8.28	15,481	128,141		Apr 30 04:11 PM
Williams Paul Anthony	SVP, Products Business	Apr 01 '26	Sale	8.44	4,000	33,760	62,681	Apr 03 04:05 PM
PAUL WILLIAMS	Officer	Apr 01 '26	Proposed Sale	8.44	4,000	33,778		Apr 01 04:07 PM
LOUIS W SULLIVAN	Director	Jan 07 '26	Proposed Sale	13.99	25,748	360,142		Jan 07 04:27 PM
LOUIS W SULLIVAN	Director	Dec 22 '25	Proposed Sale	12.77	104,695	1,336,463		Dec 22 06:22 PM
Richard Ronald	Director	Dec 05 '25	Option Exercise	5.02	25,748	129,255	124,165	Dec 09 06:01 PM
Richard Ronald	Director	Dec 05 '25	Sale	11.97	21,984	263,077	98,417	Dec 09 06:01 PM
RONALD RICHARD	Director	Dec 05 '25	Proposed Sale	11.94	32,848	392,335		Dec 05 04:04 PM
DeGolyer Donald W	Director	Nov 10 '25	Sale	10.54	17,801	187,623	119,858	Nov 12 04:13 PM
Dayal Sujata Tyagi	Director	Nov 07 '25	Sale	10.00	8,552	85,520	88,980	Nov 10 04:09 PM
DONALD DEGOLYER	Director	Nov 10 '25	Proposed Sale	10.54	17,801	187,544		Nov 10 04:06 PM
SUJATA TYAGI DAYAL	Director	Nov 07 '25	Proposed Sale	10.00	8,552	85,520		Nov 07 04:02 PM

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company's Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

M.B.A.Mr. Joseph C. Papa Jr.

Executive VP & CFOMr. Richard S. Lindahl M.B.A.

Executive Vice President of QualityMs. Coleen Glessner

Senior Vice President of Products BusinessMr. Paul A. Williams

Senior VPMs. Jessica Perl

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EBS

Emergent Biosolutions Inc

Upgrade your Finviz experience